New research in Blood Cancer Discovery shows that intravenous immunoglobulin (IVIg) reduced the risk of severe infections by 90% in patients with multiple myeloma undergoing treatment with an ...
What Is Asceniv, and Why Does It Matter? Asceniv (immune globulin intravenous) is a ready-to-use prescription medicine given intravenously. It contains concentrated human immunoglobulin G (IVIG) made ...
Incretin-based therapies and all-cause mortality and progression to multiple myeloma in patients with MGUS and type 2 diabetes: A real-world cohort study.
Author: Guido Lancman, MD, a clinical associate at the Princess Margaret Cancer Centre of the University Health Network and an adjunct assistant professor at the University of Toronto Background: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results